Successes

2001: Stavudine campaign at Yale University

Yale and its licensor agree to generic production on an HIV drug — a world first. This concession led to a 30-fold price reduction and enabled the first HIV treatment programme in the developing world.

2005: University of California at Berkeley's Socially Responsible IP Management Program

This program, which includes licensing strategies, aims to “promote widespread availability of technology and healthcare, including in the developing world.” (See UC Berkeley site)

2006: Philadelphia Consensus Statement launched

UAEM’s statement of principles has garnered the support of more than 150 luminaries, including Jeffrey Sachs, Paul Farmer, ten Nobel Laureates, top researchers and professors of intellectual property law, public health, and social policy – as well as thousands of other students and faculty at over a hundred campuses around the world.

2007: "In the Public Interest: Nine Points to Consider in Licensing University Technologies"

Leading universities publish a document which recognizes their fundamental responsibility to ensure that their innovations benefit the world’s poor. (See AUTM site)

2007: The University of British Columbia's Principles for Global Access

Already used to license an experimental new formulation of amphotericin B, a drug used worldwide for systemic fungal and parasitic infections. (See UBC site)

2008: Emory University's Technology Transfer for Global Access: Guiding Principles

Advocacy work of the UAEM chapter at Emory resulted in a policy document, “Technology Transfer for Global Access: Guiding Principles,” endorsed by the university’s president. (See Emory site)

2009: "Statement of Principles and Strategies for the Equitable Dissemination of Medical Technologies"

Leading universities, including Harvard and Yale, along with AUTM and the NIH, make a public commitment to a more explicit and detailed set of global access principles. (See AUTM site / Story at bloomberg.com)